Get the Stockscreener App
18.89
0.32%
0.06
After Hours:
18.78
-0.11
-0.58%
Avadel Pharmaceuticals Plc stock is traded at $18.89, with a volume of 3.18M.
It is up +0.32% in the last 24 hours and up +23.71% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$18.83
Open:
$18.8
24h Volume:
3.18M
Relative Volume:
1.32
Market Cap:
$1.83B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
-572.42
EPS:
-0.033
Net Cash Flow:
$5.89M
1W Performance:
+1.78%
1M Performance:
+23.71%
6M Performance:
+112.49%
1Y Performance:
+22.11%
1-Day Range:
$18.73
$19.06
1-Week Range:
$18.54
$19.06
52-Week Range:
$6.38
$19.06
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
18.89 | 1.83B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Citadel Group discloses 1.98% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Bank of America discloses 3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Bank of America discloses 3% stake in Avadel Pharmaceuticals - Investing.com
Is Avadel Pharmaceuticals plc stock supported by strong fundamentals2025 Earnings Impact & Fast Moving Stock Watchlists - newser.com
Can Avadel Pharmaceuticals plc stock deliver sustainable ROEJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Can Avadel Pharmaceuticals plc stock maintain growth trajectoryJuly 2025 Patterns & Stock Market Timing Techniques - newser.com
Real time breakdown of Avadel Pharmaceuticals plc stock performanceJuly 2025 Decliners & Verified Swing Trading Watchlists - newser.com
Will a bounce in Avadel Pharmaceuticals plc offer an exitEntry Point & Long-Term Safe Return Strategies - newser.com
Morgan Stanley discloses dealing in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley discloses dealing in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
What insider trading reveals about Avadel Pharmaceuticals plc stockAnalyst Downgrade & Consistent Return Strategy Ideas - newser.com
Leading vs lagging indicators on Avadel Pharmaceuticals plc performanceTrend Reversal & Low Risk Entry Point Guides - newser.com
How risky is Avadel Pharmaceuticals plc stock nowEarnings Beat & Safe Swing Trade Setups - newser.com
Can Avadel Pharmaceuticals plc stock rebound after recent weaknessStock Surge & Scalable Portfolio Growth Ideas - newser.com
Why Avadel Pharmaceuticals plc stock is a value investor pick2025 Momentum Check & Low Drawdown Trading Strategies - newser.com
How Avadel Pharmaceuticals plc (AWK) stock performs in volatility spikes2025 Momentum Check & High Accuracy Investment Signals - newser.com
Published on: 2025-10-31 00:36:25 - newser.com
How interest rate cuts could boost Avadel Pharmaceuticals plc stockWeekly Investment Recap & Weekly Return Optimization Plans - newser.com
How Avadel Pharmaceuticals plc (AWK) stock reacts to stronger dollar2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Hits New 1-Year HighWhat's Next? - MarketBeat
Bank of America discloses 2.98% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading activity in Avadel Pharmaceuticals - Investing.com
Strategies to average down on Avadel Pharmaceuticals plcMarket Growth Review & Capital Protection Trade Alerts - newser.com
Will earnings trigger a reversal in Avadel Pharmaceuticals plc2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is Avadel Pharmaceuticals plc stock positioned well for digital economyMarket Trend Review & High Conviction Buy Zone Picks - newser.com
Statistical indicators supporting Avadel Pharmaceuticals plc’s strengthPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Is Avadel Pharmaceuticals plc (AWK) stock cheap vs fundamentalsWeekly Trade Recap & Community Verified Trade Signals - newser.com
Is Avadel Pharmaceuticals plc stock a buy before product launchesMarket Trend Report & Smart Swing Trading Alerts - newser.com
Is Avadel Pharmaceuticals plc stock bottoming outFed Meeting & Smart Money Movement Tracker - newser.com
Published on: 2025-10-30 01:05:36 - newser.com
BlackRock discloses 6.81% stake in Avadel Pharmaceuticals - Investing.com India
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com
BlackRock discloses 6.81% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com India
Tudor Investment Corporation discloses stake in Avadel Pharmaceuticals By Investing.com - Investing.com Philippines
Why Avadel Pharmaceuticals plc stock could rally in 2025Wall Street Watch & Free Risk Controlled Daily Trade Plans - Fundação Cultural do Pará
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avadel Pharmaceuticals Plc Stock (AVDL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
| Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 11 '24 |
Buy |
10.49 |
5,000 |
52,432 |
85,500 |
| Divis Gregory J | Chief Executive Officer |
Dec 06 '24 |
Buy |
9.98 |
9,598 |
95,759 |
9,598 |
| Divis Gregory J | Chief Executive Officer |
Dec 09 '24 |
Buy |
9.82 |
402 |
3,948 |
10,000 |
| Glass Geoffrey Michael | Director |
Dec 10 '24 |
Buy |
9.84 |
20,279 |
199,641 |
75,904 |
| Palczuk Linda | Director |
Dec 06 '24 |
Buy |
10.19 |
3,000 |
30,568 |
66,400 |
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):